CanBas Co., Ltd. (4575.T)

JPY 957.0

(-2.35%)

Inventory Summary of CanBas Co., Ltd.

  • CanBas Co., Ltd.'s latest annual inventory in 2023 was 728 Thousand JPY , down -5.7% from previous year.
  • CanBas Co., Ltd.'s latest quarterly inventory in 2023 FY was 728 Thousand JPY , down -5.7% from previous quarter.
  • CanBas Co., Ltd. reported annual inventory of 772 Thousand JPY in 2022, down -27.78% from previous year.
  • CanBas Co., Ltd. reported annual inventory of 1.06 Million JPY in 2021, down -12.16% from previous year.
  • CanBas Co., Ltd. reported quarterly inventory of 728 Thousand JPY for 2023 Q4, down 0.0% from previous quarter.
  • CanBas Co., Ltd. reported quarterly inventory of - JPY for 2023 Q3, down 0.0% from previous quarter.

Annual Inventory Chart of CanBas Co., Ltd. (2023 - 2019)

Historical Annual Inventory of CanBas Co., Ltd. (2023 - 2019)

Year Inventory Inventory Growth
2023 728 Thousand JPY -5.7%
2022 772 Thousand JPY -27.78%
2021 1.06 Million JPY -12.16%
2020 1.21 Million JPY 20.85%
2019 1 Million JPY 0.0%

Peer Inventory Comparison of CanBas Co., Ltd.

Name Inventory Inventory Difference
KOHJIN BIO CO LTD 683.01 Million JPY 99.893%
PRISM BioLab Co.,LTD 17.92 Million JPY 95.94%
GNI Group Ltd. 2.33 Billion JPY 99.969%
Linical Co., Ltd. - JPY -Infinity%
Trans Genic Inc. 2.22 Billion JPY 99.967%
MEDINET Co., Ltd. 67.48 Million JPY 98.921%
Soiken Holdings Inc. 1.12 Billion JPY 99.935%
Cytori Cell Research Institute, Inc. 103.53 Million JPY 99.297%
AnGes, Inc. 1.61 Billion JPY 99.955%
OncoTherapy Science, Inc. 73.99 Million JPY 99.016%
Nxera Pharma Co., Ltd. 2.9 Billion JPY 99.975%
Immuno-Biological Laboratories Co., Ltd. 321.91 Million JPY 99.774%
NanoCarrier Co., Ltd. 184 Thousand JPY -295.652%
Carna Biosciences, Inc. 140.14 Million JPY 99.481%
D. Western Therapeutics Institute, Inc. 87.86 Million JPY 99.171%
RaQualia Pharma Inc. 147.93 Million JPY 99.508%
Chiome Bioscience Inc. 64.1 Million JPY 98.864%
Kidswell Bio Corporation 875.65 Million JPY 99.917%
PeptiDream Inc. 2.4 Billion JPY 99.97%
Oncolys BioPharma Inc. 5.34 Million JPY 86.372%
Ribomic Inc. 2.27 Million JPY 67.986%
SanBio Company Limited - JPY -Infinity%
Healios K.K. - JPY -Infinity%
BrightPath Biotherapeutics Co., Ltd. 1.00 JPY -72799900.0%
Kubota Pharmaceutical Holdings Co., Ltd. 36 Million JPY 97.978%
Delta-Fly Pharma, Inc. - JPY -Infinity%
StemRIM 29 Million JPY 97.49%
CellSource Co., Ltd. 305.92 Million JPY 99.762%
FunPep Company Limited 25.54 Million JPY 97.15%
Kringle Pharma, Inc. 364.05 Million JPY 99.8%
Stella Pharma Corporation 1.11 Billion JPY 99.935%
TMS Co., Ltd. 50.02 Million JPY 98.545%
Noile-Immune Biotech Inc. 20.9 Million JPY 96.517%
Cuorips Inc. 1.04 Million JPY 30.201%
K Pharma,Inc. 10.79 Million JPY 93.256%
Takara Bio Inc. 11.85 Billion JPY 99.994%
ReproCELL Incorporated 248.14 Million JPY 99.707%
PhoenixBio Co., Ltd. 450.58 Million JPY 99.838%
StemCell Institute Inc. 42.26 Million JPY 98.277%
Japan Tissue Engineering Co., Ltd. 228.56 Million JPY 99.681%
CellSeed Inc. 46.19 Million JPY 98.424%